Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C
Open Access
- 15 January 2009
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 360 (3) , 257-267
- https://doi.org/10.1056/nejmoa0805062
Abstract
Race has been shown to be a factor in the response to therapy for hepatitis C virus (HCV) infection, and limited data suggest that ethnic group may be as well; however, Latinos and other ethnic subpopulations have been underrepresented in clinical trials. We evaluated the effect of Latino ethnic background on the response to treatment with peginterferon alfa-2a and ribavirin in patients infected with HCV genotype 1 who had not been treated previously.Keywords
This publication has 31 references indexed in Scilit:
- Latinos and Chronic Hepatitis C: A Singular PopulationClinical Gastroenterology and Hepatology, 2008
- Changing trends in hepatitis C–related mortality in the United States, 1995‐2004†‡Hepatology, 2007
- More Advanced Hepatic Fibrosis in Hispanics with Chronic Hepatitis C Infection: Role of Patient Demographics, Hepatic Necroinflammation, and SteatosisAmerican Journal of Gastroenterology, 2006
- The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002Annals of Internal Medicine, 2006
- Progression to Cirrhosis in Latinos With Chronic Hepatitis C: Differences in Puerto Ricans With and Without Human Immunodeficiency Virus Coinfection and Along GenderJournal of Clinical Gastroenterology, 2006
- Ethnic differences in the presentation of chronic hepatitis CJournal of Viral Hepatitis, 2006
- Differences in treatment outcome for hepatitis C among ethnic groupsThe American Journal of Medicine, 2004
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Chronic hepatitis c in ethnic minority patients evaluated in Los Angeles countyAmerican Journal of Gastroenterology, 2001
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999